125 related articles for article (PubMed ID: 20677548)
21. [Guidelines for evaluation of the safety of nanomaterials].
Onishchenko GG; Archakov AI; Bessonov VV; Bokit'ko BG; Gintsburg AL
Gig Sanit; 2007; (6):3-10. PubMed ID: 18161181
[TBL] [Abstract][Full Text] [Related]
22. The potential environmental impact of engineered nanomaterials.
Colvin VL
Nat Biotechnol; 2003 Oct; 21(10):1166-70. PubMed ID: 14520401
[TBL] [Abstract][Full Text] [Related]
23. Applications of nanomedicine in dermatology: use of nanoparticles in various therapies and imaging.
Abramovits W; Granowski P; Arrazola P
J Cosmet Dermatol; 2010 Jun; 9(2):154-9. PubMed ID: 20618563
[TBL] [Abstract][Full Text] [Related]
24. [Nanotubes and fullerenes: an overview of the possible environmental and biological impact of bio-nanotechnologies].
Bottini M; Magrini A; Bottini N; Bergamaschi A
Med Lav; 2003; 94(6):497-505. PubMed ID: 14768242
[TBL] [Abstract][Full Text] [Related]
25. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products.
Fruijtier-Pölloth C
Toxicology; 2005 Oct; 214(1-2):1-38. PubMed ID: 16011869
[TBL] [Abstract][Full Text] [Related]
26. [Occupational exposure to nanoparticles. Assessment of workplace exposure].
Bujak-Pietrek S
Med Pr; 2010; 61(2):183-9. PubMed ID: 20509555
[TBL] [Abstract][Full Text] [Related]
27. Some aspects of toxic contaminants in herbal medicines.
Chan K
Chemosphere; 2003 Sep; 52(9):1361-71. PubMed ID: 12867165
[TBL] [Abstract][Full Text] [Related]
28. Review of health safety aspects of nanotechnologies in food production.
Bouwmeester H; Dekkers S; Noordam MY; Hagens WI; Bulder AS; de Heer C; ten Voorde SE; Wijnhoven SW; Marvin HJ; Sips AJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):52-62. PubMed ID: 19027049
[TBL] [Abstract][Full Text] [Related]
29. Use of topical herbal remedies and cosmetics: a questionnaire-based investigation in dermatology out-patients.
Corazza M; Borghi A; Lauriola MM; Virgili A
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1298-303. PubMed ID: 19486228
[TBL] [Abstract][Full Text] [Related]
30. [Problem of safety provision of nanodimensional objects for human health].
Khotimchenko SA; Gmoshinskiĭ IV; Tutel'ian VA
Gig Sanit; 2009; (5):7-11. PubMed ID: 20050058
[TBL] [Abstract][Full Text] [Related]
31. Detection and characterization of engineered nanoparticles in food and the environment.
Tiede K; Boxall AB; Tear SP; Lewis J; David H; Hassellov M
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Jul; 25(7):795-821. PubMed ID: 18569000
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus?
Shvedova AA; Kisin ER; Porter D; Schulte P; Kagan VE; Fadeel B; Castranova V
Pharmacol Ther; 2009 Feb; 121(2):192-204. PubMed ID: 19103221
[TBL] [Abstract][Full Text] [Related]
33. Using the WTO/TBT enquiry point to monitor tendencies in the regulation of environment, health, and safety issues affecting the chemical industry.
Pio Borges Menezes R; Maria de Souza Antunes A
Environ Int; 2005 Apr; 31(3):407-16. PubMed ID: 15734193
[TBL] [Abstract][Full Text] [Related]
34. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
35. [Contribution of research to the responsible and sustainable development of nanotechnologies].
Iavicoli S; Boccuni F
G Ital Med Lav Ergon; 2008; 30(3 Suppl):110-4. PubMed ID: 19288800
[TBL] [Abstract][Full Text] [Related]
36. Nanotechnology applications and approaches for neuroregeneration and drug delivery to the central nervous system.
Silva GA
Ann N Y Acad Sci; 2010 Jun; 1199():221-30. PubMed ID: 20633128
[TBL] [Abstract][Full Text] [Related]
37. Nanotechnology blooms, at last (Review).
Gordon EM; Hall FL
Oncol Rep; 2005 Jun; 13(6):1003-7. PubMed ID: 15870914
[TBL] [Abstract][Full Text] [Related]
38. Nanotechnology in regenerative medicine: the materials side.
Engel E; Michiardi A; Navarro M; Lacroix D; Planell JA
Trends Biotechnol; 2008 Jan; 26(1):39-47. PubMed ID: 18036685
[TBL] [Abstract][Full Text] [Related]
39. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
40. Development of textile-based high-tech products: the new challenge.
da Rocha AM
Stud Health Technol Inform; 2004; 108():330-4. PubMed ID: 15718663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
